Tissue Engineering of Bone

Tissue Engineering

Volumn , Issue , 2008, Pages 559-610

  Van Gaalen, Steven ^a   Kruyt, Moyo ^a   Meijer, Gert ^a   Mistry, Amit ^b   Mikos, Antonios ^b   Beucken, Jeroen van den ^c   Jansen, John ^c   De Groot, Klaas ^d   Cancedda, Ranieri ^e   Olivo, Christina ^a   Yaszemski, Michael ^f   Dhert, Wouter ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Rice University   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF TWENTE   (Netherlands)

^e UNIVERSITY OF GENOA   (Italy)

^f Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882860184     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370869-4.00019-7     Document Type: Chapter

References (259)

1. Acil Y., Terheyden H., et al. Three-dimensional cultivation of human osteoblast-like cells on highly porous natural bone mineral. J Biomed Mater Res 2000, 51:703-710.
2. Alden T.D., Pittman D.D., et al. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg 1999, 90(1 Suppl):109-114.
3. Alexander, J.T., Branch, C.L.J., et al. (2002). An analysis of the use of rhBMP-2 in PLIF constructs: clinical and radiolographic outcomes. Presented at AANS/CNS Section on Disorders of the Spine and Peripheral Nerves, Orlando, FL.
4. An Y.H., Woolf S.K., et al. Pre-clinical in vivo evaluation of orthopaedic bioabsorbable devices. Biomaterials 2000, 21:2635-2652.
5. Anderson J.M. The Cellular Cascades of Wound Healing 2000, EM Squared, Toronto.
6. Anderson M.L., Dhert W.J., et al. Critical size defect in the goat's os ilium. A model to evaluate bone grafts and substitutes. Clin Orthop Relat Res 1999, 364:231-239.
7. Arinzeh T.L., Peter S.J., et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003, 85A:1927-1935.
8. Ashton B.A., Allen T.D., et al. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop Relat Res 1980, 151:294-307.
9. Aubin J.E. Bone stem cells. J Cell Biochem 1998, (Suppl 31):73-82.
10. Bab I., Ashton B.A., et al. Assessment of an in vivo diffusion chamber method as a quantitative assay for osteogenesis. Calcif Tissue Int 1984, 36:77-82.
11. Bak B., Jorgensen P.H., et al. Dose response of growth hormone on fracture healing in the rat. Acta Orthop Scand 1990, 61:54-57.
12. Baksh D., Davies J.E., et al. Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp Hematol 2003, 31:723-732.
13. Banwart J.C., Asher M.A., et al. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine 1995, 20:1055-1060.
14. Baskin, D.S., Ryan, P., et al. (2002). ACDFP with cornerstone-SR allograft and plate: rhBMP-2 vs autograft. Presented at AANS/CNS Section on Disorders of the Spine and Peripheral Nerves, Orlando, FL.
15. Bensaid W., Oudina K., et al. De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng 2005, 11:814-824.
16. Bianco P., Boyde A. Confocal images of marrow stromal (Westen-Bainton) cells. Histochemistry 1993, 100:93-99.
17. Bianco P., Riminucci M., et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
18. Bobyn J.D., Mortimer E.S., et al. Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty. Clin Orthop Relat Res 1992, 274:79-96.
19. Boden S.D. Bioactive factors for bone tissue engineering. Clin Orthop 1999, 367(Suppl):S84-S94.
20. Boden S.D. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 2002, 27(16 Suppl 1):S26-S31.
21. Boden S.D., Martin G.J., et al. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 1998, 11:95-101.
22. Boden S.D., Martin G.J., et al. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 1999, 24:1179-1185.
23. Boden S.D., Zdeblick T.A., et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000, 25:376-381.
24. Boden S.D., Kang J., et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002, 27:2662-2673.
25. Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Injury 2000, 31(Suppl 4):37-47.
26. Bolander M.E. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1992, 200:165-170.
27. Borden M., Attawia M., et al. Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix. J Bone Joint Surg Br 2004, 86:1200-1208.
28. Bos G.D., Goldberg V.M., et al. Immune responses of rats to frozen bone allografts. J Bone Joint Surg Am 1983, 65:239-246.
29. Bostrom M.P., Camacho N.P. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res 1998, 355(Suppl):S274-S282.
30. Boyne P.J. Maxillofacial Surgery 1992, Saunders, Philadelphia, PA.
31. Brodke D., Pedrozo H.A., et al. Bone grafts prepared with selective cell retention technology heal canine segmental defects as effectively as autograft. J Orthop Res 2006, 24:857-866.
32. Bruder S.P., Horowitz M.C., et al. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997, 21:225-235.
33. Bruder S.P., Kraus K.H., et al. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998, 80:985-996.
34. Bruder S.P., Kurth A.A., et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998, 16:155-162.
35. Burchardt H. The biology of bone graft repair. Clin Orthop Relat Res 1983, 174:28-42.
36. Burkus J.K., Transfeldt E.E., et al. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002, 27:2396-2408.
37. Cancedda R., Mastrogiacomo M., et al. Bone marrow stromal cells and their use in regenerating bone. Novartis Found Symp 2003, 249:133-143. discussion 143-147, 170-174, 239-241.
38. Caplan A.I. Mesenchymal stem cells and gene therapy. Clin Orthop Relat Res 2000, 379(Suppl):S67-S70.
39. Caplan A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 2005, 11:1198-1211.
40. Caplan A.I., Goldberg V.M. Principles of tissue engineered regeneration of skeletal tissues. Clin Orthop Relat Res 1999, 367(Suppl):S12-S16.
41. Carpenter J.E., Hipp J.A., et al. Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model. J Bone Joint Surg Am 1992, 74:359-367.
42. Cawood J.I., Howell R.A. Reconstructive preprosthetic surgery. I. Anatomical considerations. Int J Oral Maxillofac Surg 1991, 20:75-82.
43. Charalambides C., Beer M., et al. Poor results after augmenting autograft with xenograft (Surgibone) in hip revision surgery: a report of 27 cases. Acta Orthop 2005, 76:544-549.
44. Chiou M., Xu Y., et al. Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun 2006, 343:562-644.
45. Chunmeng S., Tianmin C. Effects of plastic-adherent dermal multipotent cells on peripheral blood leukocytes and CFU-GM in rats. Transplant Proc 2004, 36:1578-1581.
46. Colter D.C., Class R., et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000, 97:3213-3218.
47. Colter D.C., Sekiya I., et al. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 2001, 98:7841-7845.
48. Contag P.R., Olomu I.N., et al. Bioluminescent indicators in living mammals. Nat Med 1998, 4:245-247.
49. Cook S.D., Wolfe M.W., et al. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 1995, 77:734-750.
50. Cormack D.H. The Circulatory System. Part Three: The Tissues of the Body 1987, Lippincott, Philadelphia, PA.
51. Cormack D.H. Bone. Part Three: The Tissues of the Body 1987, Lippincott, Philadelphia, PA.
52. Cornell C.N. Osteoconductive materials and their role as substitutes for autogenous bone grafts. Orthop Clin North Am 1999, 30:591-598.
53. Critchlow M.A., Bland Y.S., et al. The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. Bone 1995, 16:521-527.
54. Daculsi G., LeGeros R.Z., et al. Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. J Biomed Mater Res 1989, 23:883-894.
55. Damien C.J., Parsons J.R. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 1991, 2:187-208.
56. Davies J.E. Mechanisms of endosseous integration. Int J Prosthodont 1998, 11:391-401.
57. de Bruijn J.D. Tissue engineering of goat bone: osteogenic potential of goat bone marrow cells. Bioceramics 1998, 497-500.
58. de Bruyn P.H. Bone formation by fresh and frozen autogenous and homogenous transplants of bone, bone marrow and periosteum. Am J Anat 1955, 96:375-417.
59. de Groot K. Bioceramics consisting of calcium phosphate salts. Biomaterials 1980, 1:47-50.
60. Deschaseaux F., Charbord P. Human marrow stromal precursors are alpha 1 integrin subunit-positive. J Cell Physiol 2000, 184:319-325.
61. Di Nicola M., Carlo-Stella C., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
62. Duvall C.L., Taylor W.R., et al. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin deficient mice. J Bone Miner Res 2006, 22:286-297.
63. Dvorak H.F., Harvey V.S., et al. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987, 57:673-686.
64. Elsinger E.C., Leal L. Coralline hydroxyapatite bone graft substitutes. J Foot Ankle Surg 1996, 35:396-399.
65. Emans P.J., Pieper J., et al. Differential cell viability of chondrocytes and progenitor cells in tissue-engineered constructs following implantation into osteochondral defects. Tissue Eng 2006, 12:1699-1709.
66. Fazili M., van der Dussen F.M., et al. Long-term results of augmentation of the atrophic mandible. Int J Oral Maxillofac Surg 1986, 15:513-520.
67. Feeley B.T., Conduah A.H., et al. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models. J Orthop Res 2006, 24:1709-1721.
68. Fleming J.E., Cornell C.N., et al. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am 2000, 31:357-374.
69. Friedenstein A.J. Humoral nature of osteogenic activity of transitional epithelium. Nature 1962, 194:698-699.
70. Friedenstein A.Y. Induction of bone tissue by transitional epithelium. Clin Orthop Relat Res 1968, 59:21-37.
71. Friedenstein A., Kuralesova A.I. Osteogenic precursor cells of bone marrow in radiation chimeras. Transplantation 1971, 12:99-108.
72. Friedenstein A.J., Piatetzky S., et al. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966, 16:381-390.
73. Friedenstein A.J., Chailakhjan R.K., et al. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970, 3:393-403.
74. Friedenstein A.J., Gorskaja J.F., et al. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976, 4:267-274.
75. Friedenstein A.J., Ivanov-Smolenski A.A., et al. Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants. Exp Hematol 1978, 6:440-444.
76. Friedenstein A.J., Latzinik N.W., et al. Marrow microenvironment transfer by heterotopic -transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 1982, 10:217-227.
77. Friedenstein A.J., Chailakhyan R.K., et al. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987, 20:263-272.
78. Friedenstein A.J., Latzinik N.V., et al. Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner 1992, 18:199-213.
79. Friedlaender G.E. Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop Relat Res 1983, 174:58-68.
80. Friedlaender G.E. Bone banking. In support of reconstructive surgery of the hip. Clin Orthop Relat Res 1987, 225:17-21.
81. Friedlaender G.E., Perry C.R., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001, 83A(Suppl 1; Pt 2):S151-S158.
82. Fujita M., Kinoshita Y., et al. Proliferation and differentiation of rat bone marrow stromal cells on poly(glycolic acid)-collagen sponge. Tissue Eng 2005, 11:1346-1355.
83. Gazit D., Turgeman G., et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1999, 1:121-133.
84. Geesink R.G., de Groot K., et al. Bonding of bone to apatite-coated implants. J Bone Joint Surg Br 1988, 70:17-22.
85. Geesink R.G., Hoefnagels N.H., et al. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 1999, 81:710-718.
86. Gerber H.P., Vu T.H., et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628.
87. Giannoudis P.V., Dinopoulos H., et al. Bone substitutes: an update. Injury 2005, 36(Suppl 3):S20-S27.
88. Goldberg V.M., Stevenson S. Bone Transplantation 1990, Churchill Livingstone, New York.
89. Gornet, M.F., Burkus, K., et al. (2001). rh-BMP-2 with tapered cages: A prospective randomized lumbar fusion study. Presented at the Annual Meeting of the North American Spine Society, Seattle, WA.
90. Goshima J., Goldberg V.M., et al. The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop 1991, 269:183-274.
91. Griffiths A.D., Williams S.C., et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994, 13:3245-3260.
92. + fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994, 84:4164-4173.
93. Gronthos S., Simmons P.J. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 1995, 85:929-940.
94. Gupta M.C., Maitra S. Bone grafts and bone morphogenetic proteins in spine fusion. Cell Tissue Bank 2002, 3:255-267.
95. Habibovic P., Yuan H., et al. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials 2005, 26:3565-3575.
96. Habibovic P., Yuan H., et al. Relevance of osteoinductive biomaterials in critical-sized orthotopic defect. J Orthop Res 2006, 24:867-876.
97. Hacker M., Tessmar J., et al. Towards biomimetic scaffolds: anhydrous scaffold fabrication from biodegradable amine-reactive diblock copolymers. Biomaterials 2003, 24:4459-4473.
98. Hartgerink J.D., Beniash E., et al. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001, 294:1684-1688.
99. Hausman M.R., Schaffler M.B., et al. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001, 29:560-564.
100. Hedberg E.L., Kroese-Deutman H.C., et al. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. J Biomed Mater Res A 2005, 72:343-353.
101. Hedberg E.L., Shih C.K., et al. In vitro degradation of porous poly(propylene fumarate)/poly(dl-lactic-co-glycolic acid) composite scaffolds. Biomaterials 2005, 26:3215-3225.
102. Hentz V.R., Chang J. Tissue engineering for reconstruction of the thumb. N Engl J Med 2001, 344:1547-1548.
103. Hetherington V.J., Kawalec J.S., et al. Immunologic testing of xeno-derived osteochondral grafts using peripheral blood mononuclear cells from healthy human donors. BMC Musculoskelet Disord 2005, 6:36.
104. Hiltunen M.O., et al. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. Faseb J 2003, 17(9):1147-1149.
105. Hollinger J.O., Brekke J., et al. Role of bone substitutes. Clin Orthop Relat Res 1996, 324:55-65.
106. Horan P.K., Slezak S.E. Stable cell membrane labeling. Nature 1989, 340:167-168.
107. Horch R.A., Shahid N., et al. Nanoreinforcement of poly(propylene fumarate)-based networks with surface modified alumoxane nanoparticles for bone tissue engineering. Biomacromolecules 2004, 5:1990-1998.
108. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21:2529-2543.
109. Jansen J.A., Vehof J.W., et al. Growth factor-loaded scaffolds for bone engineering. J Control Release 2005, 101(1-3):127-136.
110. Janssen F.W., Oostra J., et al. A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials 2006, 27:315-323.
111. Jiang Y., Jahagirdar B.N., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418(6893):41-49.
112. Jingushi S., Bolander M.E. Biological cascades of fracture healing as models for bone-biomaterial interfacial reactions. The Bone-Biomaterial Interface 1991, University of Toronto Press, Toronto. J.E. Davies, T. Albrektsson (Eds.).
113. Johnson E.E., Urist M.R., et al. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop Relat Res 1988, 230:257-265.
114. Johnson E.E., Urist M.R., et al. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clin Orthop Relat Res 1988, 236:249-257.
115. Jones A.L., Bucholz R.W., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 2006, 88:1431-1441.
116. Joyner C.J., Bennett A., et al. Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone 1997, 21:1-6.
117. Kadiyala S., Young R.G., et al. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997, 6:125-134.
118. Kato T., Kawaguchi H., et al. Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 1998, 16:654-659.
119. Kitamura S., Ohgushi H., et al. Osteogenic differentiation of human bone marrow-derived mesenchymal cells cultured on alumina ceramics. Artif Organs 2004, 28:72-82.
120. Kitoh H., Kitakoji T., et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis - a preliminary result of three cases. Bone 2004, 35:892-898.
121. Kon E., Muraglia A., et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 2000, 49:328-337.
122. Kratchmarova I., Blagoev B., et al. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005, 308:1472-1477.
123. Kraus K.H., Kadiyala S., et al. Critically sized osteo-periosteal femoral defects: a dog model. J Invest Surg 1999, 12:115-124.
124. Krebsbach P.H., Kuznetsov S.A., et al. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997, 63:1059-1069.
125. Krebsbach P.H., Kuznetsov S.A., et al. Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 1999, 10:165-181.
126. Kroese-Deutman H.C., Ruhe P.Q., et al. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials 2005, 26:1131-1138.
127. Kruyt M.C., De Bruijn J., et al. Application and limitations of chloromethyl-benzamidodialkylcarbocyanine for tracing cells used in bone Tissue engineering. Tissue Eng 2003, 9:105-115.
128. Kruyt M.C., de Bruijn J.D., et al. Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng 2003, 9:327-336.
129. Kruyt M.C., Stijns M.M., et al. Genetic marking with the DeltaLNGFR-gene for tracing goat cells in bone tissue engineering. J Orthop Res 2004, 22:697-702.
130. Kruyt M.C., van Gaalen S.M., et al. Bone tissue engineering and spinal fusion: the potential of hybrid constructs by combining osteoprogenitor cells and scaffolds. Biomaterials 2004, 25:1463-1473.
131. Kruyt M.C., Wilson C.E., et al. The effect of cell-based bone tissue engineering in a goat transverse process model. Biomaterials 2006, 27:5099-5106.
132. Kuznetsov S., Gehron Robey P. Species differences in growth requirements for bone marrow stromal fibroblast colony formation in vitro. Calcif Tissue Int 1996, 59:265-270.
133. Langer R., Vacanti J.P. Tissue engineering. Science 1993, 260:920-926.
134. Langstaff S., Sayer M., et al. Resorbable bioceramics based on stabilized calcium phosphates. Part I: rational design, sample preparation and material characterization. Biomaterials 1999, 20:1727-1741.
135. Langstaff S., Sayer M., et al. Resorbable bioceramics based on stabilized calcium phosphates. Part II: evaluation of biological response. Biomaterials 2001, 22:135-150.
136. Le Blanc K., Tammik L., et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003, 57:11-20.
137. Letchford J., Cardwell A.M., et al. Isolation of C15: a novel antibody generated by phage display against mesenchymal stem cell-enriched fractions of adult human marrow. J Immunol Methods 2006, 308:124-137.
138. Levenberg S., Rouwkema J., et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005, 23:879-884.
139. Lieberman J.R., Daluiski A., et al. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002, 84-A:1032-1044.
140. Lin C.Y., Kikuchi N., et al. A novel method for biomaterial scaffold internal architecture design to match bone elastic properties with desired porosity. J Biomech 2004, 37:623-636.
141. Lind M., Schumacker B., et al. Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 1993, 64:553-556.
142. Liu T.M., Martina M., et al. Identification of common pathways mediating differentiation of bone marrow and adipose tissues derived human mesenchymal stem cells (MSCs) into three mesenchymal lineages. Stem Cells 2007, 25:750-760.
143. Logeart-Avramoglou D., Anagnostou F., et al. Engineering bone: challenges and obstacles. J Cell Mol Med 2005, 9:72-84.
144. Luque, E. (2002) Latest clinical results using demineralized bone materials and rhBMP-2: the Mexican experience. Presented at Total Spine: Advanced Concepts and Constructs, Cancun, Mexico.
145. Luyten F.P., Cunningham N.S., et al. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 1989, 264:13377-13380.
146. Macewan W. Observations concerning transplantation of bone. Illustrated by a case of inter-human osseous transplantation, whereby over two-thirds of the shaft of a humerus was restored. Proc Roy Soc Lond 1881, 32:232-247.
147. Maiorana C., Sigurta D., et al. Sinus elevation with alloplasts or xenogenic materials and implants: an up-to-4-year clinical and radiologic follow-up. Int J Oral Maxillofac Implants 2006, 21:426-432.
148. Majors A.K., Boehm C.A., et al. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 1997, 15:546-557.
149. Maniatopoulos C., Sodek J., et al. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988, 254:317-330.
150. Mankin H.J., Doppelt S., et al. Clinical experience with allograft implantation, The first ten years. Clin Orthop Relat Res 1983, 174:69-86.
151. Marcacci M., Kon K., et al. Stem cells associated with macroporous bioceramics for long bone repair: 6 to 7 year outcome of a pilot clinical study. Tissue Eng 2007, 13:947-955.
152. Mastrogiacomo M., Corsi A., et al. Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng 2006, 12:1261-1273.
153. Mastrogiacomo M., Papadimitropoulos A., et al. Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between bone formation and scaffold resorption. Biomaterials 2007, 28:1376-1384.
154. Meijer G.J., de Bruijn J.D., et al. Cell-based bone tissue engineering. PLoS Med 2007, 4:e9.
155. Mendes S.C.,, et al. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 2002, 8(6):911-920.
156. Meury T., Verrier S., et al. Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression. J Cell Biochem 2006, 98:992-1006.
157. Mistry A.S., Mikos A.G. Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol 2005, 94:1-22.
158. Morishita T., Honoki K., et al. Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 2006, 30:115-118.
159. Muschler G.F., Negami S., et al. Evaluation of collagen ceramic composite graft materials in a spinal fusion model. Clin Orthop Relat Res 1996, 328:250-260.
160. Muschler G.F., Boehm C., et al. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume [published erratum appears in J Bone Joint Surg Am 1998; 80: 302]. J Bone Joint Surg Am 1997, 79:1699-1709.
161. Muschler G.F., Midura R.J. Connective tissue progenitors: practical concepts for clinical applications. Clin Orthop Relat Res 2002, 395:66-80.
162. Muschler G.F., Nakamoto C., et al. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 2004, 86A:1541-1558.
163. Nakahara H., Bruder S.P., et al. In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop 1990, 259:223-232.
164. Nakajima F., Ogasawara A., et al. Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor. J Orthop Res 2001, 19:935-944.
165. Nakamae A., Sunagawa T., et al. Acceleration of surgical angiogenesis in necrotic bone with a single injection of fibroblast growth factor-2 (FGF-2). J Orthop Res 2004, 22:509-513.
166. Nakamura T., Hara Y., et al. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 1998, 13:942-949.
167. Nash T.J., Howlett C.R., et al. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 1994, 15:203-208.
168. Nevins M.L., Camelo M., et al. Evaluation of periodontal regeneration following grafting intrabony defects with bio-oss collagen: a human histologic report. Int J Periodontics Restorative Dent 2003, 23:9-17.
169. Nielsen H.M., Andreassen T.T., et al. Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 1994, 65:37-41.
170. Nikolaychik V.V., Samet M.M., et al. A new method for continual quantitation of viable cells on endothelialized polyurethanes. J Biomater Sci Polym Ed 1996, 7:881-891.
171. Nocini P.F., Schlegel K.A., et al. Two techniques for the preparation of cell-scaffold constructs suitable for sinus augmentation: steps into clinical application. Tissue Eng 2006, 12:2649-2656.
172. Ogawa R., Mizuno H., et al. Chondrogenic and osteogenic differentiation of adipose-derived stem cells isolated from GFP transgenic mice. J Nippon Med Sch 2004, 71:240-241.
173. Ohgushi H., Kotobuki N., et al. Tissue engineered ceramic artificial joint - ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 2005, 26:4654-4661.
174. Osborn J.F. Dynamic Aspects of the Implant-Bone Interface 1980, Carl Hansen Verlach, Munchen.
175. Overgaard S., Soballe K., et al. Efficiency of systematic sampling in histomorphometric bone research illustrated by hydroxyapatite-coated implants: optimizing the stereological vertical-section design. J Orthop Res 2000, 18:313-321.
176. Owen M.E. The Marrow Stromal System 1998, Cambridge University Press, Cambridge.
177. Oyajobi B.O., Lomri A., et al. Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res 1999, 14:351-361.
178. Pacheco E.M., Civelek A.C., et al. Clinico-pathological correlation of technetium bone scan in vascularization of hydroxyapatite implants, A primate model. Arch Ophthalmol 1997, 115:1173-1177.
179. Pelissier P., Villars F., et al. Influences of vascularization and osteogenic cells on heterotopic bone formation within a madreporic ceramic in rats. Plast Reconstr Surg 2003, 111:1932-1941.
180. Peng H., Usas A., et al. Converse relationship between in vitro osteogenic differentiation and in vivo bone healing elicited by different populations of muscle-derived cells genetically engineered to express BMP4. J Bone Miner Res 2004, 19:630-641.
181. Peng H., Usas A., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005, 20:2017-2027.
182. Peter S.J., Miller S.T., et al. In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res 1998, 41:1-7.
183. Petite H., Viateau V., et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000, 18:959-963.
184. Phinney D.G., Kopen G., et al. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 1999, 75:424-436.
185. Pietrzak W.S., Perns S.V., et al. Demineralized bone matrix graft: a scientific and clinical case study assessment. J Foot Ankle Surg 2005, 44:345-353.
186. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
187. Prolo D.J., Rodrigo J.J. Contemporary bone graft physiology and surgery. Clin Orthop 1985, 200:322-342.
188. Quarto R., Mastrogiacomo M., et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001, 344:385-386.
189. Radomsky M.L., Aufdemorte T.B., et al. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res 1999, 17:607-614.
190. Rengachary S.S. Bone morphogenetic proteins: basic concepts. Neurosurg Focus 2002, 13:e2.
191. Reyes M., Lund T., et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001, 98:2615-2625.
192. Riley E.H., Lane J.M., et al. Bone morphogenetic protein-2: biology and applications. Clin Orthop Relat Res 1996, 324:39-46.
193. Ripamonti U. Bone induction in nonhuman primates. An experimental study on the baboon. Clin Orthop Relat Res 1991, 269:284-294.
194. Ripamonti U., Crooks J., et al. Induction of bone formation by recombinant human osteogenic protein-1 and sintered porous hydroxyapatite in adult primates. Plast Reconstr Surg 2001, 107:977-988.
195. Rouwkema J., Boer J.D., et al. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 2006, 12:2685-2693.
196. Ruhe P.Q., Kroese-Deutman H.C., et al. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials 2004, 25:2123-2132.
197. Ruhe P.Q., Wolke J.G., et al. Calcium Phosphate Ceramics for Bone Tissue Engineering 2006, CRC Press, Boca Raton, FL.
198. Ruhe P.Q., Wolke J.G., et al. Calcium Phosphate Ceramics for Bone Tissue Engineering 2007, CRC Press, Boca Raton, FL.
199. Sakkers R.J. Bone and Bone Bonding Copolymers: A Useful Combination? 1999, UMC, Utrecht.
200. Sampath T.K., Muthukumaran N., et al. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci USA 1987, 84:7109-7113.
201. Sandhu, H.S., Kanim, L.E.A., et al. (1997). The safety and efficacy of purified native human bone morphogenetic protein for spinal fusion. A ten-year followup study. Presented at Annual Meeting of the American Academy of Orthopedic Surgeons, San Francisco, CA.
202. Schimming R., Schmelzeisen R. Tissue--engineered bone for maxillary sinus augmentation. J Oral Maxillofac Surg 2004, 62:724-729.
203. Schliephake H., Knebel J.W., et al. Use of cultivated osteoprogenitor cells to increase bone formation in segmental mandibular defects: an experimental pilot study in sheep. Int J Oral Maxillofac Surg 2001, 30:531-537.
204. Schmitz J.P., Hollinger J.O. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986, 205:299-308.
205. Sciadini M.F., Johnson K.D. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res 2000, 18:289-302.
206. Shang Q., Wang Z., et al. Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J Craniofac Surg 2001, 12:586-593. discussion 594-595.
207. Shi S., Gronthos S., et al. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 2002, 20:587-591.
208. Shi X., Hudson J.L., et al. Injectable nanocomposites of single-walled carbon nanotubes and biodegradable polymers for bone tissue engineering. Biomacromolecules 2006, 7:2237-2242.
209. Shin H., Jo S., et al. Biomimetic materials for tissue engineering. Biomaterials 2003, 24:4353-4364.
210. Silber J.S., Anderson D.G., et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003, 28:134-139.
211. Simmons P.J., Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
212. Simonsen J.L., Rosada C., et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002, 20:592-596.
213. Stewart K., Walsh S., et al. Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 1999, 14:1345-1356.
214. Street J., Winter D., et al. Is human fracture hematoma inherently angiogenic?. Clin Orthop Relat Res 2000, 378:224-237.
215. Sun J.S., Wu S.Y., et al. The role of muscle-derived stem cells in bone tissue engineering. Biomaterials 2005, 26:3953-3960.
216. Sun Q., Chen R.R., et al. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res 2005, 22:1110-1116.
217. Takagi K., Urist M.R. The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin Orthop 1982, 171:224-231.
218. Takushima A., Kitano Y., et al. Osteogenic potential of cultured periosteal cells in a distracted bone gap in rabbits. J Surg Res 1998, 78:68-77.
219. Tarkka T., et al. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 2003, 5(7):560-566.
220. Taton T.A. Nanotechnology. Boning up on biology. Nature 2001, 412:491-492.
221. Temenoff J.S., Mikos A.G. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 2000, 21:2405-2412.
222. Temenoff J.S., Lu L., et al. Bone-Tissue Engineering Using Synthetic Biodegradable Polymer Scaffolds 2000, EM Squared, Toronto.
223. Thaller S.R., Dart A., et al. The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague-Dawley rats. Ann Plast Surg 1993, 31:429-433.
224. Timmer M.D., Ambrose C.G., et al. In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate. Biomaterials 2003, 24:571-577.
225. Timmer M.D., Shin H., et al. In vitro cytotoxicity of injectable and biodegradable poly(propylene fumarate)-based networks: unreacted macromers, cross-linked networks, and degradation products. Biomacromolecules 2003, 4:1026-1033.
226. Timmer M.D. The vascular contribution to osteogenesis. V. the vasculature supplying the epiphysial cartilage in rachitic rats. J Bone Joint Surg Br 1963, 45:572-581.
227. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
228. Urist M.R., Silverman B.F., et al. The bone induction principle. Clin Orthop Relat Res 1967, 53:243-283.
229. Urist M.R., Nogami H., et al. A bone morphogenetic polypeptide. Calcif Tissue Res 1976, 21(Suppl):81-87.
230. Vacanti C.A., Bonassar L.J., et al. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med 2001, 344:1511-1514.
231. Vaccaro A.R., Patel T., et al. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004, 29:1885-1892.
232. Vaccaro A.R., Anderson D.G., et al. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine 2005, 30:2709-2716.
233. Vehof J.W., Takita H., et al. Histological characterization of the early stages of bone morphogenetic protein-induced osteogenesis. J Biomed Mater Res 2002, 61:440-449.
234. Verma I.M., Somia N. Gene therapy - promises, problems and prospects. Nature 1997, 389:239-242.
235. Viateau V., Guillemin G., et al. A technique for creating critical-size defects in the metatarsus of sheep for use in investigation of healing of long-bone defects. Am J Vet Res 2004, 65:1653-1657.
236. Villars F., Bordenave L., et al. Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF?. J Cell Biochem 2000, 79:672-685.
237. Walsh S., Jordan G.R., et al. High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology 2001, 40:74-83.
238. Wan C., He Q., et al. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. J Orthop Res 2006, 24:610-618.
239. Wan M., Cao X. BMP signaling in skeletal development. Biochem Biophys Res Commun 2005, 328:651-657.
240. Warnke P.H., Wiltfang J., et al. Man as living bioreactor: fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials 2006, 27:3163-3167.
241. Wenger A., Stahl A., et al. Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng 2004, 10(9-10):1536-1547.
242. Westen H., Bainton D.F. Association of alkaline-phosphatase-positive reticulum cells in bone marrow with granulocytic precursors. J Exp Med 1979, 150:919-937.
243. Williams D. Revisiting the definition of biocompatibility. Med Device Technol 2003, 14:10-13.
244. Williams D.F. The Williams' Dictionary of Biomaterials 1999, Liverpool University Press, Liverpool.
245. Wilson C., Dhert W., et al. Evaluating 3D bone tissue engineered constructs with different seeding densities using the alamar blue assay and the effect on in vivo bone formation. J Mater Sci Mater Med 2002, 13:1265-1269.
246. Wilson C.E., de Bruijn J.D., et al. Design and fabrication of standardized hydroxyapatite scaffolds with a defined macro-architecture by rapid prototyping for bone-tissue-engineering research. J Biomed Mater Res A 2004, 68:123-132.
247. Wilson C.E., Kruyt M.C., et al. A new in vivo screening model for posterior spinal bone formation: comparison of ten calcium phosphate ceramic material treatments. Biomaterials 2006, 27:302-314.
248. Winter G.D., Simpson B.J., et al. Heterotopic bone formed in a synthetic sponge in the skin of young pigs. Nature 1969, 223(201):88-90.
249. Wozney J.M. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992, 32:160-167.
250. Wozney J.M., Rosen V., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
251. Yaszemski M.J., Payne R.G., et al. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996, 17:175-185.
252. Yoshimoto H., Shin Y.M., et al. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003, 24:2077-2082.
253. Yuan, H. (2001). Osteoinduction of calcium phosphates, Faculty of Medicine: Biomaterials Research Group, 2001, Leiden, The Netherlands, p. 156.
254. Yuan H., et al. A preliminary study on osteoinduction of two kinds of calcium phosphate ceramics. Biomaterials 1999, 20(19):1799-1806.
255. Yuan H., van Blitterswijk C.A., et al. A comparison of bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) implanted in muscle and bone of dogs at different time periods. J Biomed Mater Res A 2006, 78:139-147.
256. Yuan J., Cui L., et al. Repair of canine mandibular bone defects with bone marrow stromal cells and porous beta-tricalcium phosphate. Biomaterials 2007, 28:1005-1013.
257. Zdeblick, T.A., Helm, S.E., et al. (2001) Laparoscopic approach with tapered metal cages: rhBMP-2 vs. autograft. Presented at Annual Meeting of the North American Spine Society, Seattle, WA.
258. Zhang X. A Study of Prorous Block HA Ceramics and its Osteogenesis 1991, Elsevier Science, Amsterdam.
259. Zhu L., Liu W., et al. Tissue-engineered bone repair of goat-femur defects with osteogenically induced bone marrow stromal cells. Tissue Eng 2006, 12:423-433.